About the Company
We do not have any company description for HERON THERAPEUTICS, INC. /DE/ at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $HRTX News
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript March 12, 2024 Heron Therapeutics, Inc. isn't one of ...
Commit To Buy Heron Therapeutics At $2, Earn 22.4% Annualized Using Options
Investors eyeing a purchase of Heron Therapeutics Inc (Symbol: HRTX) stock, but cautious about paying the going market price of $2.80/share, might benefit from considering selling puts among the ...
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
SAN DIEGO, March 12, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the ...
Heron Therapeutics: Q4 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $10.7 million in its fourth quarter. The San Diego-based company said it had a loss of 7 cents ...
Heron Therapeutics Inc HRTX
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Q4 2023 Heron Therapeutics Inc Earnings Call
Kevin Warner; SVP of Medical Affairs strategy engagements; Heron Therapeutics Inc William Forbes; EVP, Chief Development Officer; Heron Therapeutics Inc Ira Duarte; Chief Financial Officer; Heron ...
Heron Therapeutics Inc HRTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...